Comparison of the Lipid-Lowering Effects of Pitavastatin 4 mg Versus Pravastatin 40 mg in Adults With Primary Hyperlipidemia or Mixed (Combined) Dyslipidemia: A Phase IV, Prospective, US, Multicenter, Randomized, Double-blind, Superiority Trial

Autor: Sponseller, Craig A., Morgan, Roger E., Kryzhanovski, Vladimir A., Campbell, Stuart E., Davidson, Michael H.
Zdroj: In Clinical Therapeutics 1 August 2014 36(8):1211-1222
Databáze: ScienceDirect
Externí odkaz: